<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:department>Biosciences</gtr:department><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6184714F-C2F9-4D4A-BF81-55F6159D64AE"><gtr:id>6184714F-C2F9-4D4A-BF81-55F6159D64AE</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Eric</gtr:otherNames><gtr:surname>Beardmore</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FI018263%2F1"><gtr:id>A80AEDDF-EBC3-40BF-ADF3-91E962CEB766</gtr:id><gtr:title>Bacteriophage and Antibiotic Resistance: a Mathematical and Imaging Approach (C-DIP enhancement)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/I018263/1</gtr:grantReference><gtr:abstractText>While scientific research was usually conducted in centuries past by loan, gentleman scientists,modern research is different. It needs people with different skills and different scientific trainingto come together with a common vision to solve a common problem.Think of a large task, like building a plane. It needs control engineers, material scientists,software engineers, fluid dynamicists, test pilots, to name but a few of the types of peoplewho might be involved. Ask yourself, how does a software engineer with a training in thedevelopment of programming languages, say, talk to a metallurgist or chemist in order tosolve the problems they encounter on a daily basis in the aeronautical industries?Of course, in industrial contexts one answer lies in training as the path to constructing a planeis largely known. But in science, there are no well-developed training programmes that allowpeople to come together to solve the big problems, we might not even know what people toput together in order to solve them. So, we need patience, lots of it, and trust but we also need funding and helpwith the process of getting ideas from one field to permeate into another.Often, as a mathematician, when I express my ideas to biologist colleagues, they first tell methat I am mad, that I must be wrong because there are experimental results from decadespast that contradict my thinking. However, over time, with enough coffee and patience we canexplore each others viewpoint and crystalise and then distill the idea down to its bare minimum. We thensee whether there really is something that mathematical thinking can bring to biology, or to physicsor chemistry.This can be a personal and painful process, but it is worthwhile in that the amalgam of two sets of ideaslead to new independent thinking and new ideas. However, this is not a route or an approach commonly funded by research councils. In this case EPSRC have been explicit in their desire for research themes that aimto bridge these gaps between disciplines and to really foster avenues of communication where few ornone currently exist. The funding associated with this award will be put to good use to create alively and relaxed research environment where we can express our mad ideas and see if they can beput to good use to solve important problems in a range of fields that spans physics, biology and mathematics.If the recent past is a guide to the near future, we expect this endeavour will lead to a number of new and important scientific insights.</gtr:abstractText><gtr:potentialImpactText>An impact summary is not required, according to the following text in an email I received from Shaz Kahn/Zoe Brown: ...Please do not submit an impact plan, a project plan/Gantt chart or any nominated reviewers.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-06-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2010-12-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>83702</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>It has been used to inform the design of mathematical models by AstraZeneca Oncology Modelling unit with whom we are now working to design better bacterial and cancer chemotherapies. This is a large and ongoing project that is not possible to summarise in this box but has results in AZ part-funding my laboratory.

We've also now started to build a low-cost biomedical device (akin to a spectrophotometer) for measuring antibiotic resistance properties of bacteria based on outputs of this award.

Schools have shown some interest in using this as part of A level Biology and we are trying to make more devices to service that need.</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>F73C6C0F-C908-4C27-8AE9-D5A9B5CB6CBA</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56bc7282d86a18.07426729</gtr:outcomeId><gtr:sector>Chemicals,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>I have looked at virus and antibiotic resistance in species of bacteria, producing new principles for infectious disease treatment that may have applications to cancer. The core idea is that the evolution of resistance (encoded in DNA-based SNPs and similar mutations) can alter drug interactions (like drug synergy) through time. This we showed how to exploit to design more potent therapies than those that do not account for SNP-based changes during treatment. Discussions are underway with clinicians as to how to apply these ideas to hard-to-treat chronic infections.</gtr:description><gtr:exploitationPathways>In the synthetic phage community, in antibiotic pharmacology, anywhere people are seeking evolution-aware treatments of disease.</gtr:exploitationPathways><gtr:id>437025B1-3BA1-433F-9102-363F58D79159</gtr:id><gtr:outcomeId>56bc73b02eeb92.89533553</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6F51E10C-4286-4FA4-B021-BC501CB2B1EB</gtr:id><gtr:title>Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a5d101c90c15f6eb106ba4cdee52a1d"><gtr:id>3a5d101c90c15f6eb106ba4cdee52a1d</gtr:id><gtr:otherNames>Peters R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>NDqLP9ow7nQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AF8972B-3249-4FE8-AE70-D54BF5A36BA1</gtr:id><gtr:title>Bistable expression of virulence genes in salmonella leads to the formation of an antibiotic-tolerant subpopulation.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/180c5290d5174d25b4bda49292759969"><gtr:id>180c5290d5174d25b4bda49292759969</gtr:id><gtr:otherNames>Arnoldini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>546388ba5c2231.76508873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F5AB49-2257-4A8E-ADED-C19277B92C82</gtr:id><gtr:title>The form of a trade-off determines the response to competition.</gtr:title><gtr:parentPublicationTitle>Ecology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5d05cef4dfae64fd24a51f41c3053f1"><gtr:id>c5d05cef4dfae64fd24a51f41c3053f1</gtr:id><gtr:otherNames>Maharjan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1461-023X</gtr:issn><gtr:outcomeId>doi_15808__ele_12159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20CAC090-D46B-4906-8EF0-35A73F42082C</gtr:id><gtr:title>Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd3288bb1e1810c0bb2d5ce3a1bbb60"><gtr:id>cdd3288bb1e1810c0bb2d5ce3a1bbb60</gtr:id><gtr:otherNames>Fuentes-Hernandez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>56bc7414925ed1.70825654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DAB50EB-23E4-46F4-9299-BBD656A648F5</gtr:id><gtr:title>Selecting against antibiotic-resistant pathogens: optimal treatments in the presence of commensal bacteria.</gtr:title><gtr:parentPublicationTitle>Bulletin of mathematical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a581bc3738efff51a5a77c133b08b3e1"><gtr:id>a581bc3738efff51a5a77c133b08b3e1</gtr:id><gtr:otherNames>Pe?a-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0092-8240</gtr:issn><gtr:outcomeId>pm_15808_28_22057950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFFC240-AC90-4498-BB09-D123A8F18582</gtr:id><gtr:title>When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc1ce8cdbd2c070490543cfed04941c1"><gtr:id>bc1ce8cdbd2c070490543cfed04941c1</gtr:id><gtr:otherNames>Pena-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>doi_15808_io_1001540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BF5A04D-D21F-4447-A86D-856047307E98</gtr:id><gtr:title>The optimal deployment of synergistic antibiotics: a control-theoretic approach.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a581bc3738efff51a5a77c133b08b3e1"><gtr:id>a581bc3738efff51a5a77c133b08b3e1</gtr:id><gtr:otherNames>Pe?a-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>pm_15808_28_22628215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B78D5AC-6401-4B35-B0FA-F492779B2DD0</gtr:id><gtr:title>Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences and engineering : MBE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f857b8b470160d6707934a1b8cf8f80"><gtr:id>8f857b8b470160d6707934a1b8cf8f80</gtr:id><gtr:otherNames>Beardmore RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1547-1063</gtr:issn><gtr:outcomeId>QCB54djUjVx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39D3589-709D-4EA6-87DB-6D5FE88BC846</gtr:id><gtr:title>Metabolic trade-offs and the maintenance of the fittest and the flattest.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f857b8b470160d6707934a1b8cf8f80"><gtr:id>8f857b8b470160d6707934a1b8cf8f80</gtr:id><gtr:otherNames>Beardmore RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>QU3G9uG1CdP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E93632C8-C31D-47BD-A8E7-4E1EBEEBA56F</gtr:id><gtr:title>Rotating antibiotics selects optimally against antibiotic resistance, in theory.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences and engineering : MBE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f857b8b470160d6707934a1b8cf8f80"><gtr:id>8f857b8b470160d6707934a1b8cf8f80</gtr:id><gtr:otherNames>Beardmore RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1547-1063</gtr:issn><gtr:outcomeId>hn1oNcjESKq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E3C6702-D830-4104-9F54-96ADEE5FDEF7</gtr:id><gtr:title>Genomics of Rapid Adaptation to Antibiotics: Convergent Evolution and Scalable Sequence Amplification</gtr:title><gtr:parentPublicationTitle>Genome Biology and Evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/829b4ebe6eab021eafdb1bc4eb2e95cb"><gtr:id>829b4ebe6eab021eafdb1bc4eb2e95cb</gtr:id><gtr:otherNames>Laehnemann D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>546388f9d44e61.08420143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76FA2102-B759-4569-8EB0-0964CE148828</gtr:id><gtr:title>Biophysical mechanisms that maintain biodiversity through trade-offs.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c9c32f01ae348ebd2058c5d64a626eb"><gtr:id>6c9c32f01ae348ebd2058c5d64a626eb</gtr:id><gtr:otherNames>Meyer JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56bc74313619e8.72371088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ECEAB40-24DB-48C9-9CA5-EBB5682A9CE2</gtr:id><gtr:title>Testing the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a581bc3738efff51a5a77c133b08b3e1"><gtr:id>a581bc3738efff51a5a77c133b08b3e1</gtr:id><gtr:otherNames>Pe?a-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>54638a68164781.19781222</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/I018263/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>DEA11FBC-BEED-4EDD-890B-97D728462D26</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Mathematical sciences</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02B9E893-AC2F-436D-BF88-28E1AC827F5D</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Continuum Mechanics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>93E27C3B-6D00-4F18-BBE3-96C05C8F92B2</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Non-linear Systems Mathematics</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>